Security
10x Genomics, Inc. Class A Common Stock · TXG
TXGNASDAQCommon stockCurrentCIK 1770787Updated Oct 8, 2026
TXG price & chart
Loading TradingView…
NASDAQ:TXG on TradingView ↗About the company
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X, Facebook, Bluesky or YouTube.
In the news
10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025 News provided by 10x Genomics, Inc. Oct 09, 2025, 16:05 ET Share this article Share to X Share this article Share to X PLEASANTON, Calif. , Oct. 9, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG ), a leader in si ↗
10x Genomics Reports Second Quarter 2025 Financial Results News provided by 10x Genomics, Inc. Aug 07, 2025, 16:05 ET Share this article Share to X Share this article Share to X PLEASANTON, Calif. , Aug. 7, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG ), a leader in single cell and spatial b ↗
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 1,027,361,000Source | 937,794,000Source | 1,030,066,000Source | 979,970,000Source | 929,668,000Source | 1,015,759,000Source | 903,393,000Source | 922,913,000Source | 1,041,365,000Source | 918,636,000Source | 965,143,000Source | 1,028,980,000Source |
| Property, Plant and Equipment, NetUSD | 232,534,000Source | 258,759,000Source | 215,324,000Source | 239,710,000Source | 263,285,000Source | 220,591,000Source | 246,087,000Source | 269,486,000Source | 226,711,000Source | 252,648,000Source | 279,571,000Source | 289,328,000Source |
| GoodwillUSD | 4,511,000Source | 4,511,000Source | 6,918,000Source | 4,511,000Source | 4,511,000Source | 4,511,000Source | 4,511,000Source | 4,511,000Source | 4,511,000Source | 4,511,000Source | 4,511,000Source | 4,511,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 64,759,000Source | 16,149,000Source | 61,160,000Source | 14,714,000Source | 16,658,000Source | 59,910,000Source | 15,192,000Source | 16,129,000Source | 62,329,000Source | 15,671,000Source | 16,616,000Source | 22,858,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | — | — | — | — | — | — | — | — | 344,067,000Source | 359,284,000Source | 219,746,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 43,779,000Source | 83,525,000Source | 47,545,000Source | 49,977,000Source | 91,178,000Source | 39,031,000Source | 52,549,000Source | 91,305,000Source | 47,013,000Source | 87,862,000Source | 114,832,000Source | 104,211,000Source |
| Inventory, NetUSD | 61,956,000Source | 94,050,000Source | 52,616,000Source | 68,968,000Source | 88,272,000Source | 53,487,000Source | 74,710,000Source | 83,189,000Source | 56,341,000Source | 83,107,000Source | 73,706,000Source | 81,629,000Source |
| Assets, CurrentUSD | 659,827,000Source | 593,893,000Source | 674,671,000Source | 655,661,000Source | 579,155,000Source | 669,733,000Source | 579,730,000Source | 567,093,000Source | 684,451,000Source | 584,387,000Source | 596,022,000Source | 635,035,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 19,195,000Source | 18,159,000Source | 19,393,000Source | 20,365,000Source | 19,612,000Source | 20,261,000Source | 25,566,000Source | 20,785,000Source | 22,208,000Source | 20,016,000Source | 18,789,000Source | 16,578,000Source |
| Operating Lease, Right-of-Use AssetUSD | 63,650,000Source | 59,579,000Source | 56,685,000Source | 62,700,000Source | 60,872,000Source | 58,390,000Source | 55,577,000Source | 62,850,000Source | 60,450,000Source | 57,290,000Source | 65,361,000Source | 69,882,000Source |
| Other Assets, NoncurrentUSD | 1,879,000Source | 4,903,000Source | 15,308,000Source | 2,674,000Source | 5,187,000Source | 2,624,000Source | 2,296,000Source | 2,844,000Source | 2,913,000Source | 4,129,000Source | 3,062,000Source | 2,392,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 242,241,000Source | 214,990,000Source | 204,520,000Source | 206,691,000Source | 205,610,000Source | 201,435,000Source | 196,498,000Source | 204,079,000Source | 245,039,000Source | 208,502,000Source | 224,100,000Source | 223,237,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 2,000Source | 2,000Source | 2,000Source | 2,000Source | 2,000Source | 2,000Source | 2,000Source | 2,000Source | 2,000Source | 2,000Source | 2,000Source | 2,000Source |
| Retained Earnings (Accumulated Deficit)USD | -1,494,339,000Source | -1,418,019,000Source | -1,541,992,000Source | -1,466,867,000Source | -1,382,266,000Source | -1,524,061,000Source | -1,501,405,000Source | -1,344,369,000Source | -1,510,591,000Source | -1,467,047,000Source | -1,284,420,000Source | -1,029,321,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 138,000Source | 32,000Source | 77,000Source | 220,000Source | -430,000Source | 114,000Source | -367,000Source | -456,000Source | 225,000Source | -493,000Source | -429,000Source | -4,335,000Source |
| Stockholders' Equity Attributable to ParentUSD | 785,120,000Source | 722,804,000Source | 825,546,000Source | 773,279,000Source | 724,058,000Source | 814,324,000Source | 706,895,000Source | 718,834,000Source | 796,326,000Source | 710,134,000Source | 741,043,000Source | 805,743,000Source |
| Additional Paid in Capital, Common StockUSD | 2,279,319,000Source | 2,140,789,000Source | 2,367,459,000Source | 2,239,924,000Source | 2,106,752,000Source | 2,338,269,000Source | 2,208,665,000Source | 2,063,657,000Source | 2,306,690,000Source | 2,177,672,000Source | 2,025,890,000Source | 1,839,397,000Source |
| Liabilities and EquityUSD | 1,027,361,000Source | 937,794,000Source | 1,030,066,000Source | 979,970,000Source | 929,668,000Source | 1,015,759,000Source | 903,393,000Source | 922,913,000Source | 1,041,365,000Source | 918,636,000Source | 965,143,000Source | 1,028,980,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 147,324,000Source | 121,235,000Source | 118,509,000Source | 112,221,000Source | 111,019,000Source | 113,598,000Source | 107,900,000Source | 108,733,000Source | 153,454,000Source | 117,633,000Source | 127,162,000Source | 130,957,000Source |
| Operating Lease, Liability, CurrentUSD | 10,543,000Source | 9,415,000Source | 12,015,000Source | 9,669,000Source | 10,820,000Source | 11,330,000Source | 9,443,000Source | 11,127,000Source | 10,985,000Source | 9,286,000Source | 11,521,000Source | 9,037,000Source |
| Accounts Payable, CurrentUSD | 18,069,000Source | 26,210,000Source | 20,694,000Source | 15,938,000Source | 21,248,000Source | 17,425,000Source | 10,068,000Source | 20,216,000Source | 12,733,000Source | 12,909,000Source | 15,738,000Source | 21,599,000Source |
| Operating Lease, Liability, NoncurrentUSD | 76,442,000Source | 76,461,000Source | 66,781,000Source | 77,075,000Source | 78,662,000Source | 70,059,000Source | 70,631,000Source | 81,049,000Source | 73,376,000Source | 73,327,000Source | 83,849,000Source | 86,139,000Source |
| Other Liabilities, NoncurrentUSD | 6,394,000Source | 4,945,000Source | 6,556,000Source | 6,125,000Source | 4,571,000Source | 6,418,000Source | 5,398,000Source | 4,510,000Source | 6,471,000Source | 5,029,000Source | 4,275,000Source | 6,141,000Source |
| Additional Financial Items | ||||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 605,000Source | 915,000Source | 206,000Source | 652,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 9,957,000Source | 8,022,000Source | 36,199,000Source | 35,879,000Source | 35,512,000Source | 25,368,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 22,642,000Source | 31,076,000Source | 109,118,000Source | 140,749,000Source | 166,950,000Source | 136,848,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -7,980,000Source | -35,325,000Source | -41,314,000Source | -26,951,000Source | 10,613,000Source | 18,948,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -2,702,000Source | -8,058,000Source | -27,953,000Source | 9,777,000Source | -7,871,000Source | 21,192,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 4,782,000Source | -2,547,000Source | -2,126,000Source | -3,354,000Source | -6,017,000Source | 5,858,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -310,000Source | 709,000Source | -447,000Source | 136,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 26,120,000Source | 34,351,000Source | 136,050,000Source | 6,664,000Source | -15,197,000Source | -33,606,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 4,000,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -1,311,000Source | -1,893,000Source | -13,438,000Source | -32,631,000Source | 133,492,000Source | -350,887,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 1,597,000Source | 1,893,000Source | 5,935,000Source | 12,393,000Source | 48,601,000Source | 131,661,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -8,417,000Source | 422,000Source | 6,803,000Source | 10,914,000Source | 13,669,000Source | 15,817,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 16,319,000Source | 32,994,000Source | 129,899,000Source | -15,217,000Source | 131,931,000Source | -368,720,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 432,709,000Source | 398,159,000Source | 502,512,000Source | 397,712,000Source | 490,285,000Source | 377,061,000Source | 473,966,000Source | 344,067,000Source | 359,284,000Source | 227,353,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 436,000Source | 841,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | -278,000Source | 462,000Source | 2,391,000Source | 5,641,000Source | 4,927,000Source | 3,925,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -73,000Source | 114,000Source | 484,000Source | -164,000Source | -33,000Source | -44,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 25,264,000Source | 33,910,000Source | 25,616,000Source | 27,245,000Source | 22,642,000Source | 31,076,000Source | 108,804,000Source | 140,749,000Source | 166,950,000Source | 136,848,000Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | 31,200,000Source | 33,900,000Source | 32,900,000Source | 22,800,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | — | — | 2,500,000Source | 2,100,000Source | 1,200,000Source | 200,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | — | — | — | — | -1,086,000Source |
| Gain (Loss) on Termination of LeaseUSD | — | — | — | — | — | — | — | — | — | -1,000,000Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| GoodwillUSD | — | — | 4,511,000Source | 4,511,000Source | 6,918,000Source | 4,511,000Source | 4,511,000Source | 4,511,000Source | 4,511,000Source | 4,511,000Source | 4,511,000Source | 4,511,000Source |
| Income Tax Expense (Benefit)USD | — | — | -733,000Source | 1,315,000Source | -714,000Source | 2,459,000Source | 623,000Source | 852,000Source | 3,637,000Source | 4,927,000Source | 6,336,000Source | 4,029,000Source |
| InterestExpenseNonoperatingUSD | — | — | -3,000Source | 2,000Source | 0Source | 3,000Source | — | 0Source | 0Source | 4,000Source | — | — |
| Investment Income, InterestUSD | — | — | 5,199,000Source | 4,971,000Source | 4,797,000Source | 4,271,000Source | 5,014,000Source | 3,686,000Source | 20,048,000Source | 18,448,000Source | 16,906,000Source | 6,647,000Source |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | -3,000Source | -1,718,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -27,472,000Source | -35,753,000Source | -17,931,000Source | 34,538,000Source | -13,470,000Source | -34,358,000Source | -43,544,000Source | -182,627,000Source | -255,099,000Source | -166,000,000Source |
| Nonoperating Income (Expense)USD | — | — | 4,037,000Source | 7,047,000Source | 910,000Source | 6,871,000Source | 4,199,000Source | 5,822,000Source | 21,078,000Source | 16,859,000Source | 16,566,000Source | 5,973,000Source |
| Operating ExpensesUSD | — | — | 132,549,000Source | 147,878,000Source | 132,052,000Source | 94,958,000Source | 123,224,000Source | 144,773,000Source | 504,866,000Source | 609,041,000Source | 674,642,000Source | 563,967,000Source |
| Operating Lease, Impairment LossUSD | — | — | — | — | — | — | 0Source | 114,000Source | 814,000Source | — | 4,900,000Source | — |
| Other Nonoperating Income (Expense)USD | — | — | -1,165,000Source | 2,078,000Source | -3,887,000Source | 2,603,000Source | -815,000Source | 2,136,000Source | 1,030,000Source | -1,585,000Source | -307,000Source | -198,000Source |
| Payments of Financing CostsUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 5,814,000Source | 5,409,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | — | — | — | — | — | — | 25,000,000Source | 0Source | 125,200,000Source | 25,782,000Source | 82,825,000Source | 18,528,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | — | — | 21,226,000Source |
| Restructuring CostsUSD | — | — | — | — | — | — | — | — | — | — | 2,500,000Source | 4,200,000Source |
| Restructuring Costs and Asset Impairment ChargesUSD | — | — | — | — | — | — | — | — | 1,253,000Source | — | — | — |
| Debt Securities, Available-for-sale, Realized Gain (Loss) | — | — | —Source | —Source | — | —Source | — | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 149,002,000Source | 151,654,000Source | 151,036,000Source | 172,908,000Source | 150,843,000Source | 154,883,000Source | 642,823,000Source | 610,785,000Source | 618,727,000Source | 516,409,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Selling, General and Administrative ExpenseUSD | — | — | 75,355,000Source | 81,704,000Source | 78,661,000Source | 74,434,000Source | 66,377,000Source | 89,728,000Source | 316,134,000Source | 344,343,000Source | 343,330,000Source | 298,300,000Source |
| Operating Income (Loss)USD | — | — | -32,242,000Source | -41,485,000Source | -19,555,000Source | 30,126,000Source | -17,046,000Source | -39,328,000Source | -60,985,000Source | -194,559,000Source | -265,329,000Source | -167,944,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -1,165,000Source | 2,078,000Source | -3,887,000Source | 2,603,000Source | -815,000Source | 2,136,000Source | 1,030,000Source | -1,585,000Source | -307,000Source | -198,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -28,205,000Source | -34,438,000Source | -18,645,000Source | 36,997,000Source | -12,847,000Source | -33,506,000Source | -39,907,000Source | -177,700,000Source | -248,763,000Source | -161,971,000Source |
| Income Tax Expense (Benefit)USD | — | — | -733,000Source | 1,315,000Source | -714,000Source | 2,459,000Source | 623,000Source | 852,000Source | 3,637,000Source | 4,927,000Source | 6,336,000Source | 4,029,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -27,472,000Source | -35,753,000Source | -17,931,000Source | 34,538,000Source | -13,470,000Source | -34,358,000Source | -43,544,000Source | -182,627,000Source | -255,099,000Source | -166,000,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.22Source | -0.3Source | -0.14Source | 0.28Source | -0.1Source | -0.28Source | -0.35Source | -1.52Source | -2.18Source | -1.46Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.22Source | -0.3Source | -0.14Source | 0.28Source | -0.1Source | -0.28Source | -0.35Source | -1.52Source | -2.18Source | -1.46Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 125,502,291Source | 120,733,030Source | 129,984,169Source | 123,755,409Source | 128,291,153Source | 122,606,091Source | 124,749,885Source | 120,451,550Source | 117,165,036Source | 113,858,684Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 125,502,291Source | 120,733,030Source | 129,984,169Source | 124,509,720Source | 128,291,153Source | 122,606,091Source | 124,749,885Source | 120,451,550Source | 117,165,036Source | 113,858,684Source |
| Interest Expense (non-operating)USD | — | — | -3,000Source | 2,000Source | 0Source | 3,000Source | — | 0Source | 0Source | 4,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 3,947,000Source | 4,218,000Source | 6,783,000Source | 3,893,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | — | — | 2,500,000Source | 2,100,000Source | 1,200,000Source | 200,000Source |
| Gross ProfitUSD | — | — | 100,307,000Source | 106,393,000Source | 112,497,000Source | 125,084,000Source | 106,178,000Source | 105,445,000Source | 443,881,000Source | 414,482,000Source | 409,313,000Source | 396,023,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 33,000Source | 476,000Source |
| Investment Income, InterestUSD | — | — | 5,199,000Source | 4,971,000Source | 4,797,000Source | 4,271,000Source | 5,014,000Source | 3,686,000Source | 20,048,000Source | 18,448,000Source | 16,906,000Source | 6,647,000Source |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | -3,000Source | -1,718,000Source | — |
| Nonoperating Income (Expense)USD | — | — | 4,037,000Source | 7,047,000Source | 910,000Source | 6,871,000Source | 4,199,000Source | 5,822,000Source | 21,078,000Source | 16,859,000Source | 16,566,000Source | 5,973,000Source |
| Operating ExpensesUSD | — | — | 132,549,000Source | 147,878,000Source | 132,052,000Source | 94,958,000Source | 123,224,000Source | 144,773,000Source | 504,866,000Source | 609,041,000Source | 674,642,000Source | 563,967,000Source |
| Restructuring CostsUSD | — | — | — | — | — | — | — | — | — | — | 2,500,000Source | 4,200,000Source |
Filing attachments
ex-991_2026x01x11.htm · 8-K · 2026-01-12
Exhibit 99.1 10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results PLEASANTON, Calif., January 11, 2026 - 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth quarter and full year ended December 31, 2025. Preliminary, Unaudited Select Fourth Quarter 2025 Financial Results • Revenue of approximately $166.0 million for the three months ended December 31, 2025, represent…
Read attachment ↗